Purpose: The purpose of this study is to identify controllable treatment-environment-related factors affecting the timing of a central line-associated bloodstream infection (CLABSI) onset in children with cancer with central venous catheters (CVC). Design: This study is a secondary data analysis with the data extracted from electronic medical records in a tertiary hospital in South Korea. This study was conducted by reviewing electronic medical records of 470 pediatric cancer patients younger than the age of 18 years from 2010 to 2016. Method: The timing of a CLABSI onset was identified through the onset of CLABSI and the duration of catheterization. Cox proportional hazards regression analysis was used to estimate the impact of variables...
Introduction: Central line-associated bloodstream infection (CLABSI) is a public health problem that...
INTRODUCTION: This study aims to document and analyze the central venous catheter (CVC)-related comp...
Purpose: Central venous lines (CVL) in children with acute lymphoblastic leukemia (ALL) provide...
Objective: To assess the central line-associated bloodstream infection (CLABSI) rate and risk factor...
Background: Central line-associated bloodstream infection (CLABSI) is a serious complication in hema...
Central line-associated bloodstream infections (CLABSIs) are still a major cause of morbidity and mo...
ABSTRACT Objectives: To determine the risk factors for acquiring central line-associated blood str...
###EgeUn###Central line–associated bloodstream infections (CLABSIs) are still a major cause of morbi...
Icelandic Cancer Society, Reykjavik, IcelandBackground: Central venous lines (CVLs) are essential fo...
© 2018 Dr. Joshua WolfAlthough long-term central venous catheters (CVCs) are essential to paediatric...
BACKGROUND Central line-associated bloodstream infections (CLABSIs) are among the most common compl...
Poster Session - Nursing: abstract no. P-0560This journal suppl. entitled: Supplement: SIOP Abstratc...
Background Central venous line (CVL) placement in children is often necessary for treatment and may ...
Background/Purpose: In neutropenic children with hematologic malignancies, the optimal timing of imp...
Clinical research. Presentation Type: Oral presentation. Introduction: Central Line Associated Blood...
Introduction: Central line-associated bloodstream infection (CLABSI) is a public health problem that...
INTRODUCTION: This study aims to document and analyze the central venous catheter (CVC)-related comp...
Purpose: Central venous lines (CVL) in children with acute lymphoblastic leukemia (ALL) provide...
Objective: To assess the central line-associated bloodstream infection (CLABSI) rate and risk factor...
Background: Central line-associated bloodstream infection (CLABSI) is a serious complication in hema...
Central line-associated bloodstream infections (CLABSIs) are still a major cause of morbidity and mo...
ABSTRACT Objectives: To determine the risk factors for acquiring central line-associated blood str...
###EgeUn###Central line–associated bloodstream infections (CLABSIs) are still a major cause of morbi...
Icelandic Cancer Society, Reykjavik, IcelandBackground: Central venous lines (CVLs) are essential fo...
© 2018 Dr. Joshua WolfAlthough long-term central venous catheters (CVCs) are essential to paediatric...
BACKGROUND Central line-associated bloodstream infections (CLABSIs) are among the most common compl...
Poster Session - Nursing: abstract no. P-0560This journal suppl. entitled: Supplement: SIOP Abstratc...
Background Central venous line (CVL) placement in children is often necessary for treatment and may ...
Background/Purpose: In neutropenic children with hematologic malignancies, the optimal timing of imp...
Clinical research. Presentation Type: Oral presentation. Introduction: Central Line Associated Blood...
Introduction: Central line-associated bloodstream infection (CLABSI) is a public health problem that...
INTRODUCTION: This study aims to document and analyze the central venous catheter (CVC)-related comp...
Purpose: Central venous lines (CVL) in children with acute lymphoblastic leukemia (ALL) provide...